Cargando…

Antitumor effect of lysine-isopeptides

Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compounds were of high purity, low polydispersity and high stereochemical purity. The effect of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Szende, B, Szökán, Gy, Tyihá, E, Pál, K, Gáborjányi, R, Almás, M, Khlafulla, A R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116434/
https://www.ncbi.nlm.nih.gov/pubmed/12076354
http://dx.doi.org/10.1186/1475-2867-2-4
_version_ 1782120257638367232
author Szende, B
Szökán, Gy
Tyihá, E
Pál, K
Gáborjányi, R
Almás, M
Khlafulla, A R
author_facet Szende, B
Szökán, Gy
Tyihá, E
Pál, K
Gáborjányi, R
Almás, M
Khlafulla, A R
author_sort Szende, B
collection PubMed
description Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compounds were of high purity, low polydispersity and high stereochemical purity. The effect of the compounds was tested on a human erythroleukemia cell line (K-562) and on four transplantable mouse tumors (L1210 lymphoid leukemia, P38 macrophage derived tumor, Ehrlich ascites carcinoma, Lewis lung tumor /LLT/). In case of the L1210 and P388 tumors and the Ehrlich carcinoma, survival of the animals was used as an indicator of the effect. In case of the Lewis lung tumor, the number and size of metastases in the lung and/or liver of treated and untreated mice were used as indicators. The polymers of polymerisation degree 80–120 (Mw 10.2–15.4 KD) showed the strongest antiproliferative effect both on K562 cells and the tumors growing in vivo. This effect was manifest with a significantly higher survival rate as compared to the control (L1210, P38, Ehrlich ascites), furthermore, by a decrease in the number and size of liver and lung metastases (LLT).
format Text
id pubmed-116434
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1164342002-09-18 Antitumor effect of lysine-isopeptides Szende, B Szökán, Gy Tyihá, E Pál, K Gáborjányi, R Almás, M Khlafulla, A R Cancer Cell Int Primary Research Isopeptides (ε-peptides) of lysine, with a given Mw and low polydispersity (10–400 units), were synthesized to study the relationship between their chemical structure and biological effect. The designed compounds were of high purity, low polydispersity and high stereochemical purity. The effect of the compounds was tested on a human erythroleukemia cell line (K-562) and on four transplantable mouse tumors (L1210 lymphoid leukemia, P38 macrophage derived tumor, Ehrlich ascites carcinoma, Lewis lung tumor /LLT/). In case of the L1210 and P388 tumors and the Ehrlich carcinoma, survival of the animals was used as an indicator of the effect. In case of the Lewis lung tumor, the number and size of metastases in the lung and/or liver of treated and untreated mice were used as indicators. The polymers of polymerisation degree 80–120 (Mw 10.2–15.4 KD) showed the strongest antiproliferative effect both on K562 cells and the tumors growing in vivo. This effect was manifest with a significantly higher survival rate as compared to the control (L1210, P38, Ehrlich ascites), furthermore, by a decrease in the number and size of liver and lung metastases (LLT). BioMed Central 2002-05-17 /pmc/articles/PMC116434/ /pubmed/12076354 http://dx.doi.org/10.1186/1475-2867-2-4 Text en Copyright © 2002 Szende et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Primary Research
Szende, B
Szökán, Gy
Tyihá, E
Pál, K
Gáborjányi, R
Almás, M
Khlafulla, A R
Antitumor effect of lysine-isopeptides
title Antitumor effect of lysine-isopeptides
title_full Antitumor effect of lysine-isopeptides
title_fullStr Antitumor effect of lysine-isopeptides
title_full_unstemmed Antitumor effect of lysine-isopeptides
title_short Antitumor effect of lysine-isopeptides
title_sort antitumor effect of lysine-isopeptides
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116434/
https://www.ncbi.nlm.nih.gov/pubmed/12076354
http://dx.doi.org/10.1186/1475-2867-2-4
work_keys_str_mv AT szendeb antitumoreffectoflysineisopeptides
AT szokangy antitumoreffectoflysineisopeptides
AT tyihae antitumoreffectoflysineisopeptides
AT palk antitumoreffectoflysineisopeptides
AT gaborjanyir antitumoreffectoflysineisopeptides
AT almasm antitumoreffectoflysineisopeptides
AT khlafullaar antitumoreffectoflysineisopeptides